Fycompa Suspension
Product Images NDC 62856-290

Product Visual Gallery

This gallery contains 42 technical images submitted to the FDA as part of the official labeling for Fycompa (NDC 62856-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eisai Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fycompa 01)

Chemical structure of perampanel, the active ingredient in Fycompa. The diagram shows the molecular arrangement including aromatic rings and a cyanide group, with a hydration notation of 3/4 H2O.*

FDA Label Image

Figure 1. Median Percent Reduction In Seizure Frequency Per 28 Days From Baseline To Treatment Period (Fycompa 02)

A bar graph displaying seizure reduction percentages from baseline in three separate studies comparing Fycompa at different doses (4, 8, 12 mg/day) versus placebo. Each study shows higher median seizure reduction with Fycompa compared to placebo, with statistical significance indicated. Sample sizes for each group are noted below the bars.*

FDA Label Image

Figure 2. Proportion Of Patients Exhibiting Different Percent Reductions During The Maintenance Phase Over Baseline Across All Three Trials. (Fycompa 03)

A bar chart comparing the proportion of patients (%) across different categories of response from worse to 100 for placebo and Fycompa (perampanel) at doses of 4 mg/day, 8 mg/day, and 12 mg/day. The chart shows patient distribution percentages by treatment group across five response intervals.*

FDA Label Image

Figure 3. Proportion Of Patients Exhibiting Different Percent Reductions During The Maintenance Phase Over Baseline In Primary Generalized Tonic-clonic Seizure Frequency. (Fycompa 04)

A bar chart comparing the proportion of patients (percentage) between two treatment groups, Placebo and Fycompa, across different outcome categories: Worse, 0 to <25%, 25 to <50%, 50 to <75%, and 75 to 100%. The chart includes group sizes of 81 patients each and shows higher proportions of patients in the 75 to 100% category for the Fycompa group compared to Placebo.*

FDA Label Image

Figure A (Fycompa 05)

An instructional diagram depicting components labeled as bottle, box, bottle adapter, and syringes. The illustration shows an open box containing a bottle with a separate bottle adapter and two syringes, indicating preparation or use steps without additional text or branding.*

FDA Label Image

Figure B (Fycompa 06)

An instructional illustration showing a labeled syringe with parts identified as tip, barrel, plunger, and dosage indicators. The close-up highlights the dosage scale marked in milliliters from 15 mL to 20 mL.*

FDA Label Image

Figure C (Fycompa 07)

An instructional illustration labeled Figure B showing a hand holding a bottle at an angle and shaking it. The text advises to "shake well." This image demonstrates the proper technique to shake the bottle before use.*

FDA Label Image

Figure D (Fycompa 08)

A simple line drawing labeled 'Figure C' depicting a bottle adapter, shown as a cylindrical component with multiple ridges designed to fit onto a bottle.*

FDA Label Image

Figure E (Fycompa 09)

An instructional illustration showing a hand holding a bottle and pressing down on the cap, with a downward arrow indicating the action of pushing or pressing the cap down. This likely demonstrates how to open or close a safety cap on a pharmaceutical bottle.*

FDA Label Image

Figure F (Fycompa 0a)

An instructional diagram showing a syringe with labeled parts including tip, barrel, dosage indicators, and plunger. The syringe is marked with volume measurements from 5 mL to 20 mL, with a zoomed-in view highlighting the dosage indicator scale between 13 mL and 20 mL.*

FDA Label Image

Figure G (Fycompa 0b)

An instructional illustration labeled 'Figure F' showing a hand holding a syringe above an open bottle, with a downward arrow indicating placing or inserting the syringe into the bottle. This diagram likely demonstrates how to draw fluid from the bottle using the syringe.*

FDA Label Image

Figure H (Fycompa 0c)

An instructional illustration showing two hands preparing an oral liquid dose with a syringe. One hand holds a bottle upside down, attaching the tip to the syringe, which is held by the other hand for drawing medication.*

FDA Label Image

Figure I (Fycompa 0d)

An instructional illustration showing a syringe being withdrawn from a bottle, with a hand holding the bottle steady and an arrow pointing upwards indicating the direction to pull the syringe out.*

FDA Label Image

Figure J (Fycompa 0e)

An illustration showing a person administering oral medication using a syringe, with the syringe placed near the person's mouth.*

FDA Label Image

Figure K (Fycompa 0f)

Illustration showing the use of a syringe to draw liquid from a cup by pulling the plunger up and then dispensing the liquid by pushing the plunger down, with drops falling from the syringe tip. This instructional diagram demonstrates proper syringe use for liquid medication administration.*

FDA Label Image

Ndc 62856-272-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii2 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 10)

An instructional illustration labeled Figure K showing a hand opening a child-resistant cap or safety cap on a bottle, demonstrating proper technique for accessing the container contents.*

FDA Label Image

Ndc 62856-274-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii4 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 11)

Fycompa 2 mg tablets label with active ingredient perampanel. The label indicates 30 tablets per package, prescription use only, distributed by Eisai Inc. Storage instructions specify 25°C (77°F) with permitted excursions. Non-varnish lot/expiration serialization area and barcode are visible.*

FDA Label Image

Ndc 62856-276-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii6 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 12)

Label for Fycompa (perampanel) tablets, 2 mg strength, by Eisai Inc. The label specifies oral tablet form with 30 tablets in the package. Storage instructions indicate 25°C (77°F) with permitted excursions from 15°C to 30°C (59°F to 86°F). The label includes the NDC number 62856-272-30 and states Rx only. There is a barcode and a designated non-varnish serialization area.*

FDA Label Image

Ndc 62856-278-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii8 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient (Fycompa 13)

Label for Fycompa (perampanel) 2 mg oral tablets, distributed by Eisai Inc. The label includes storage instructions (store at 25°C with excursions between 15°C-30°C), a note to pharmacists to dispense the accompanying medication guide, and indicates a 90-tablet count. Also shown are the NDC 62856-272-90, a barcode, and a designated lot/expiration area.*

FDA Label Image

Ndc 62856-280-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii10 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 14)

Fycompa (perampanel) tablets 2 mg sample carton, labeled as a 2 Week Sample Kit. The packaging indicates it contains fourteen 2 mg oral tablets, distributed by Eisai Inc. The label includes warnings to keep out of reach of children and states it is a professional sample not for sale, Rx only. Instructions advise opening the card and pushing tablets through from inside, and to see prescribing information inside the card.*

FDA Label Image

Ndc 62856-282-9090 Tabletsrx Onlyfycompa™(perampanel)tabletsciii12 mgattention Pharmacist:dispense The Accompanyingmedication Guide To Each Patient. (Fycompa 15)

Dosage and use instructions for Fycompa (perampanel) 2 mg tablets, showing a two-week daily tablet schedule. The label states to take one tablet orally once daily at bedtime and indicates the package contains fourteen 2 mg tablets. Storage instructions specify 25°C (77°F) with permitted excursions from 15°C to 30°C (59°F to 86°F). Additional prescribing information is advised.*

FDA Label Image

Ndc 62856-290-380.5 mg/mlrx Onlyfycompa®(perampanel)oral Suspensionciii0.5 mg/mlattention Pharmacist:dispense The Enclosedmedication Guide And Instructions For Usewith Each Prescription. (Fycompa 16)

Packaging label for Fycompa (perampanel) tablets 2 mg oral tablets by Eisai Inc. The label is for a 2 Week Sample Kit containing fourteen 2 mg tablets. The label includes instructions to push the tablet through the card, a warning to keep out of reach of children, and advises that this is a professional sample not for sale. It also directs to see prescribing information inside the card.*

FDA Label Image

Fycompa 17

Fycompa (perampanel) tablets 2 mg sample kit package label from Eisai Inc. The label states the pack contains fourteen 2 mg tablets. Instructions indicate taking one tablet orally once daily at bedtime for two weeks, with a daily calendar layout for Week 1 and Week 2. Storage instructions specify 25°C (77°F) with excursions allowed to 15-30°C (59-86°F).*

FDA Label Image

Fycompa 18

Label for Fycompa (perampanel) oral tablets, containing 4 mg strength. The label indicates a package of 30 tablets with NDC 62856-274-30, distributed by Eisai Inc. Storage instructions and pharmacist dispensing guidance are also included alongside a barcode.*

FDA Label Image

Fycompa 19

Label for Fycompa (perampanel) tablets, 4 mg strength, in a package containing 30 tablets. The label shows storage instructions, distributor Eisai Inc., and a barcode. It includes the NDC 62856-274-30 and a note for pharmacists to dispense the Medication Guide with the product.*

FDA Label Image

Fycompa 1a

Label for Fycompa (perampanel) tablets, 4 mg strength, oral dosage form. The label indicates 90 tablets per container, prescription only, and includes storage instructions at 25°C with permitted excursions. Distributed by Eisai Inc., Woodcliff Lake, NJ. The label also contains a pharmacist alert to dispense the accompanying medication guide and a barcode.*

FDA Label Image

Fycompa 1b

Packaging label for Fycompa (perampanel) tablets, 4 mg strength, provided as a 2 Week Sample Kit. The label states the package contains fourteen 4 mg tablets. It includes warnings to keep out of reach of children and directs to see prescribing information inside the card for dosage details. The label is distributed by Eisai Inc.*

FDA Label Image

Fycompa 1c

Packaging label for Fycompa (perampanel) tablets, 4 mg strength. The label indicates it contains fourteen 4 mg tablets in a sample kit. It includes instructions for a two-week oral dosing schedule with one tablet taken once daily at bedtime, displayed in circular day markers for Week 1 and Week 2. The label also lists storage conditions and mentions prescription information availability, with Eisai Inc. as the labeler.*

FDA Label Image

Fycompa 1d

Fycompa 6 mg oral tablets label by Eisai Inc. The label indicates 30 tablets per container with the Rx only designation. It shows the active ingredient perampanel, storage instructions at 25°C with permitted excursions, and directs pharmacists to dispense the accompanying medication guide. The label includes a barcode and serialization area.*

FDA Label Image

Fycompa 1e

Label for Fycompa (perampanel) 6 mg oral tablets, in a package of 30 tablets. The label includes storage instructions, manufacturer details (Eisai Inc.), and a barcode. The product is Rx only and includes a notice for pharmacists to dispense the Medication Guide with each prescription.*

FDA Label Image

Fycompa 1f

The label for Fycompa (perampanel) 6 mg oral tablets, containing 90 tablets per bottle. The label includes storage instructions (25°C/77°F with permitted excursions), dosage/use directions to see accompanying prescribing information, and a pharmacist warning to dispense the Medication Guide with each patient. The product is distributed by Eisai Inc., Woodcliff Lake, NJ.*

FDA Label Image

Fycompa 20

Fycompa 8 mg tablets packaging label showing the brand name with generic name perampanel, dosage strength 8 mg, and 30 tablet count. Label includes storage instructions at 25°C, distributed by Eisai Inc., with a barcode and a non-varnish serialization area. The label also advises pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Fycompa 21

Fycompa 8 mg tablets label from Eisai Inc. The label shows product name, generic name perampanel, dosage strength 8 mg, quantity 30 tablets, and NDC 62856-278-30. Storage instructions, pharmacist dispensing notice, and barcode are also visible. Manufactured in Japan.*

FDA Label Image

Fycompa 22

Label for Fycompa (perampanel) 8 mg oral tablets, distributed by Eisai Inc. The label indicates a package containing 90 tablets with storage instructions at 25°C (77°F) with permitted excursions. It includes a barcode, a lot/expiration area, and directs pharmacists to dispense the accompanying Medication Guide.*

FDA Label Image

Fycompa 23

Label for Fycompa (perampanel) tablets, 10 mg strength, in a package of 30 tablets. The label includes storage instructions, manufacturer Eisai Inc., and a note to pharmacists to dispense the Medication Guide. It also notes the product is Rx only and made in Italy.*

FDA Label Image

Fycompa 24

Fycompa (perampanel) 10 mg oral tablets label from Eisai Inc. The label indicates a 30-tablet package, prescription only (Rx only). Storage instructions specify 25°C (77°F) with permissible excursions between 15°C-30°C (59°F-86°F). The label includes a caution for pharmacists to dispense the Medication Guide with each prescription. It also shows a barcode and serialization area.*

FDA Label Image

Fycompa 25

Label for Fycompa 10 mg tablets, containing the active ingredient perampanel. The label indicates the product is prescription-only with a package size of 90 tablets. It includes storage instructions, a barcode, and notes that the medication guide should be dispensed to each patient. The labeler is Eisai Inc., Woodcliff Lake, NJ.*

FDA Label Image

Fycompa 26

Fycompa 12 mg tablets label in oral dosage form, manufactured and distributed by Eisai Inc. The label displays storage instructions, dosage and use note, the National Drug Code (NDC 62856-282-30), a pharmacy dispensing caution, lot/expiration information area, and a barcode.*

FDA Label Image

Fycompa 27

The image shows a packaging label for Fycompa (perampanel) 12 mg tablets by Eisai Inc. It is a prescription drug with a package count of 30 tablets. The label includes storage instructions to keep at 25°C with permitted excursions, pharmacist dispensing instructions, and a bar code with the NDC 62856-282-30.*

FDA Label Image

Fycompa 28

Fycompa 12 mg tablets label shows a prescription oral tablet containing perampanel. The label indicates the package contains 90 tablets, is Rx only, and is distributed by Eisai Inc. Storage instructions note controlled room temperature. The label includes a barcode and a section marked LOT/EXP AREA.*

FDA Label Image

Fycompa 29

Label for Fycompa (perampanel) oral suspension, 0.5 mg/mL, in a 340 mL bottle. The label includes directions for oral administration, storage instructions, and a barcode. It is distributed by Eisai Inc., Woodcliff Lake, NJ. The label specifies Rx only and advises shaking well before use.*

FDA Label Image

Fycompa 2a

Packaging label for Fycompa (perampanel) oral suspension, 0.5 mg/mL strength, in a 340 mL bottle. The label includes administration instructions for oral use, storage conditions, and a warning to dispense the enclosed Medication Guide with each prescription. The product is distributed by Eisai Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.